Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2020 Jun 3;12:4171–4180. doi: 10.2147/CMAR.S248251

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2020 Zhao et al.

This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).

PMC Copyright notice

MiR-625 targets Resistin to inhibit EMT of NSCLC cells via downregulation of the PI3K/AKT/Snail pathway. (A and B) Immunoblots showing the expression levels of Resistin, p-AKT, p-PI3K, E-cadherin, Snail, Twist1, and Vimentin in A549 and H226 cells transfected with miR-625 mimic/inhibitor and/or si-Resistin. *P<0.05 compared to the Blank group, #P<0.05 compared to the miR-625 inhibitor group.